TLX

Telix Pharmaceuticals Limited (TLX)

US
$ 18.8-2.19%

Price Chart

Key Statistics

Market Cap
$ 5.23B
P/E Ratio
173.44
Revenue (TTM)
$ 645.68M
Volume
28.85K
52W High
$ 30.36
52W Low
$ 13.61
Dividend Yield
0.00%
Beta
2.38

Technicals

50-Day MA
15.6043
200-Day MA
15.6043
52 Week High
30.36
52 Week Low
13.61

About TLX

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare dis.

Employees
N/A
Headquarters
North Melbourne, VIC
CEO
Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg